The study conducted by Kim et al. (2020) and published in the International Journal of Molecular Sciences explores the therapeutic potential of volatile terpenes and terpenoids from forests for inflammatory diseases. In their investigation, the authors delve into the anti-inflammatory properties of various natural compounds, including myrcene, which is found in forest-derived terpenes. The article highlights myrcene as one of the bioactive compounds that possess anti-inflammatory effects and discusses its potential application in managing inflammatory diseases. For example, the research conducted by McDougall and McKenna (2022) and published in the International Journal of Molecular Sciences investigates the anti-inflammatory properties of the cannabis terpene myrcene using a rat adjuvant monoarthritis model. In their study, the authors delve into the potential of myrcene to alleviate inflammation and pain associated with arthritic conditions. Through their experiments, they demonstrate that myrcene exhibits both anti-inflammatory and analgesic effects in the rat adjuvant monoarthritis model. The study’s findings highlight myrcene’s potential as a natural therapeutic agent for managing inflammatory conditions and related pain. By revealing the anti-inflammatory mechanisms of myrcene, this research contributes to the growing body of evidence supporting the use of plant-derived compounds in the development of novel anti-inflammatory treatments.